S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.39 (-0.41%)
AAPL   137.60 (+0.18%)
MSFT   252.40 (-0.29%)
FB   193.36 (+1.08%)
GOOGL   2,177.44 (-1.37%)
AMZN   2,150.35 (+0.18%)
TSLA   662.73 (-6.58%)
NVDA   166.83 (-2.58%)
BABA   86.70 (-1.13%)
NIO   16.42 (-1.44%)
AMD   93.44 (-3.34%)
CGC   5.52 (-5.96%)
MU   68.87 (-0.76%)
T   20.39 (+0.89%)
GE   75.27 (-0.62%)
F   12.50 (-2.72%)
DIS   102.25 (-0.86%)
AMC   11.97 (-8.49%)
PFE   52.48 (+3.61%)
PYPL   80.50 (-0.96%)
NFLX   186.23 (+1.50%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.39 (-0.41%)
AAPL   137.60 (+0.18%)
MSFT   252.40 (-0.29%)
FB   193.36 (+1.08%)
GOOGL   2,177.44 (-1.37%)
AMZN   2,150.35 (+0.18%)
TSLA   662.73 (-6.58%)
NVDA   166.83 (-2.58%)
BABA   86.70 (-1.13%)
NIO   16.42 (-1.44%)
AMD   93.44 (-3.34%)
CGC   5.52 (-5.96%)
MU   68.87 (-0.76%)
T   20.39 (+0.89%)
GE   75.27 (-0.62%)
F   12.50 (-2.72%)
DIS   102.25 (-0.86%)
AMC   11.97 (-8.49%)
PFE   52.48 (+3.61%)
PYPL   80.50 (-0.96%)
NFLX   186.23 (+1.50%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.39 (-0.41%)
AAPL   137.60 (+0.18%)
MSFT   252.40 (-0.29%)
FB   193.36 (+1.08%)
GOOGL   2,177.44 (-1.37%)
AMZN   2,150.35 (+0.18%)
TSLA   662.73 (-6.58%)
NVDA   166.83 (-2.58%)
BABA   86.70 (-1.13%)
NIO   16.42 (-1.44%)
AMD   93.44 (-3.34%)
CGC   5.52 (-5.96%)
MU   68.87 (-0.76%)
T   20.39 (+0.89%)
GE   75.27 (-0.62%)
F   12.50 (-2.72%)
DIS   102.25 (-0.86%)
AMC   11.97 (-8.49%)
PFE   52.48 (+3.61%)
PYPL   80.50 (-0.96%)
NFLX   186.23 (+1.50%)
S&P 500   3,901.36 (+0.01%)
DOW   31,261.90 (+0.03%)
QQQ   288.39 (-0.41%)
AAPL   137.60 (+0.18%)
MSFT   252.40 (-0.29%)
FB   193.36 (+1.08%)
GOOGL   2,177.44 (-1.37%)
AMZN   2,150.35 (+0.18%)
TSLA   662.73 (-6.58%)
NVDA   166.83 (-2.58%)
BABA   86.70 (-1.13%)
NIO   16.42 (-1.44%)
AMD   93.44 (-3.34%)
CGC   5.52 (-5.96%)
MU   68.87 (-0.76%)
T   20.39 (+0.89%)
GE   75.27 (-0.62%)
F   12.50 (-2.72%)
DIS   102.25 (-0.86%)
AMC   11.97 (-8.49%)
PFE   52.48 (+3.61%)
PYPL   80.50 (-0.96%)
NFLX   186.23 (+1.50%)

Group: Tax rich to fund vaccines for poor hit by pandemic

Sunday, January 16, 2022 | Kelvin Chan, AP Business Writer


File---File picture taken Jan.24, 2022 shows a police security guard on the roof of a hotel ahead of the World Economic Forum in Davos, Switzerland. (AP Photo/Markus Schreiber,file)

LONDON (AP) — Anti-poverty organization Oxfam called Monday for governments to impose a one-time 99% tax on the world's billionaires and use the money to fund expanded production of vaccines for the poor — part of an effort to combat global inequality widened by the coronavirus pandemic.

The ranks of the super-rich have swelled during the pandemic thanks to ample financial stimulus that pumped up stocks, the group said. Meanwhile, poor countries have suffered more than their share from COVID-19 because of unequal access to vaccines, which have mostly gone to rich nations, Oxfam said in a report aimed at informing discussions at the World Economic Forum’s online gathering of political and business leaders this week.

"The pandemic has been a billionaire bonanza," Oxfam International Executive Director Gabriela Bucher said in an interview. "When governments did the rescue packages and pumped trillions into the economy and to financial markets in order to support the economy for all, what happened is a lot of it went into the pockets of the billionaires."

Vaccine development has been one of the pandemic's success stories but Bucher said they've been "hoarded by the rich countries" seeking to protect pharmaceutical monopolies.

Since the pandemic erupted in March 2020, a new billionaire has been minted almost every day. The fortunes of the world's 10 richest men — including Elon Musk, Jeff Bezos and Bill Gates — more than doubled to $1.5 trillion, making them six times more wealthy than the world's poorest 3.1 billion people, Oxfam said.

Meanwhile, 160 million more people have been forced into poverty during the pandemic, Oxfam said, citing numbers from the Forbes 2021 Billionaires List, Credit Suisse's Global Wealth Databook and the World Bank.

Oxfam called for rich countries to waive intellectual property rules on COVID-19 vaccines in an effort to expand their production.


A one-off 99% tax on the 10 richest men’s pandemic windfalls could earn more than $800 billion and be used to fund that effort and other progressive social spending, the group said.

The money "would be able to pay for vaccines for the whole world, have health systems for everyone," Bucher said. "We would also be able to compensate for the damage of climate change and have policies that address gender-based violence," while still leaving the 10 billionaires $8 billion richer than they were at the start of the pandemic, she added.

It's not all doom and gloom. The group noted that the U.S. and China, the world's two biggest economies, are starting to consider policies aimed at countering inequality, such as raising tax rates on the rich and taking action against corporate monopolies.

"The point is extreme inequality is not inevitable and this is why it brings us hope," Bucher said.

Oxfam has long sought to inspire debate at the annual gathering of business and political elites typically held in the Swiss ski resort of Davos. The pandemic forced organizers to put off the event for a second year, instead holding virtual sessions where political leaders will be joined by business executives and campaigning groups such as Oxfam.


7 Stocks That are Ready For a Santa Claus Rally

With the end of the year approaching, many investors are looking to rebalance their portfolios. That typically means casting a critical eye at some of your strong performers and making a decision on whether they will move higher. And one thing that can dip the balance in favor of retaining a stock is the likelihood of a Santa Claus rally.

The technical definition of a Santa Claus rally is a rally that starts in the last few trading days of the year after the Christmas holiday. In recent years, however, that definition has been expanded to take into account a December rally. And with Black Friday beginning earlier and earlier and really not ending until after the holiday's end, this makes some sense.

So will there be a rally in 2021? I wouldn’t bet against it. The market continues to want to move higher and January is historically a strong month for stocks. With that said, we believe quality should still matter. Here are seven stocks that stand to benefit with or without a Santa Claus rally.

View the "7 Stocks That are Ready For a Santa Claus Rally".


Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.